PATENT CLAIM ANALYSIS

Application Number: 16014295
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "210210"]

Abstract:
Provided are benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof. Also provided is a method for treating cancer by using a pharmaceutical composition including the benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers.

Claim (Index 4):
A method for treating cancer in a subject in need thereof, comprising administering a therapeutically effective amount of a pharmaceutical composition to the subject, wherein the pharmaceutical composition comprises the benzenesulfonamide derivative or the pharmaceutically acceptable salt thereof of  claim 1 , and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15387221', '15036384', '14361548', '14453502', '15566872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6980976967989391
- 35 USC 102 Novelty (BERT): 0.4613697130560444
- Combined Prediction Score: 0.6744248984246496
- Mean Citation Score: 169.93924199999995
- Max Citation Score: 180.09967
- Similarity Product: 162.17572720780134

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test